【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Biosimilars: Overview
• Comparative analysis of biosimilars and generics
• Biosimilars market opportunities
• Challenges for new entrants
PART 06: Erythropoietin: An overview
• Clinical uses of EPO
• Abusive uses of EPO
• Risks of EPO use
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Pipeline portfolio
• Phase III pipeline portfolio
• Phase II pipeline portfolio
• Phase I pipeline portfolio
• Pre-clinical pipeline portfolio
PART 09: Marketed products portfolio
PART 10: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 11: Market segmentation by application
• End-stage renal disease
• Cancer
• HIV
• Wounds and neural disease
PART 12: Market segmentation by product
• First-generation erythropoietin formulation
• Second-generation erythropoietin formulation
• Biosimilars
PART 13: Geographical segmentation
• Erythropoietin drugs market in EMEA
• Erythropoietin drugs market in Europe
• Erythropoietin drugs market in Americas
• Erythropoietin drugs market in US
• Erythropoietin drugs market in APAC
• Erythropoietin drugs market in China
• Erythropoietin drugs market in Japan
• Market overview
PART 14: Market drivers
• Rise in number of patent expiries
• Need for cost-effective treatment
• Increase in CKD and dialysis patient pool
PART 15: Impact of drivers
PART 16: Market challenges
• Physicians’ reluctance to prescribe biosimilars
• Multiple manufacturing complexities
• Development of alternative therapies
• Complicated regulatory framework
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Advent of biosimilars expected to improve the treatment rates
• Outsourcing of biosimilar manufacturing activities
• High growth in the emerging markets
PART 19: Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 20: Key vendor analysis
• F. Hoffmann-La Roche
• Amgen
• Johnson & Johnson
• Kyowa Hakko Kirin
PART 21: Appendix
• List of abbreviations
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for erythropoietin drugs 2016
Exhibit 03: Impact of key customer segments on the market 2016
Exhibit 04: Definition of biosimilars in different regions
Exhibit 05: Comparison between biosimilars and generics
Exhibit 06: Factors affecting biologics and biosimilars market
Exhibit 07: Impact of biosimilars cost savings on various sectors
Exhibit 08: Factors affecting success of biosimilars
Exhibit 09: Biosimilars industry: Point-of-view
Exhibit 10: Factors influencing uptake of biosimilars
Exhibit 11: Global erythropoietin drugs market: Strategic factors for new biosimilar entrants
Exhibit 12: Challenges for new entrants
Exhibit 13: Historical timeline of EPO development
Exhibit 14: Globally approved EPO biosimilars
Exhibit 15: Overview of global erythropoietin drugs market (2016-2021)
Exhibit 16: Global erythropoietin drugs market 2016-2021 ($ billions)
Exhibit 17: Key strategies in global erythropoietin drugs market
Exhibit 18: Prospects of the global erythropoietin drugs market
Exhibit 19: Global erythropoietin drugs market snapshot: Developed and emerging markets 2016
Exhibit 20: New opportunities in global erythropoietin drugs market
Exhibit 21: Impact of factors affecting the market 2016 and 2021
Exhibit 22: Factors affecting global erythropoietin drugs market
Exhibit 23: Five forces analysis
Exhibit 24: Share of pipeline molecules
Exhibit 25: Pipeline share of biologics and biosimilars in global erythropoietin drugs market 2016
Exhibit 26: Phase III pipeline portfolio
Exhibit 27: Phase II pipeline portfolio
Exhibit 28: Phase I pipeline portfolio
Exhibit 29: Pre-clinical pipeline portfolio
Exhibit 30: Share of biologics and biosimilars in global erythropoietin drugs market 2016
Exhibit 31: Synopsis of marketed products
Exhibit 32: Biosimilars market segmentation by end-user 2016
Exhibit 33: Global erythropoietin drugs market segmentation in by product type 2016
Exhibit 34: Snapshot of global erythropoietin drugs market by geography
Exhibit 35: Erythropoietin drugs market revenue by geography 2016-2021 ($ billions)
Exhibit 36: Overview of erythropoietin drugs market in EMEA (2016)
Exhibit 37: Erythropoietin drugs market in EMEA 2016-2021 ($ billions)
Exhibit 38: Share of erythropoietin drugs market in Europe 2016
Exhibit 39: Erythropoietin drugs market in Europe 2016-2021 ($ billions)
Exhibit 40: Europe erythropoietin drugs market: Opportunity analysis
Exhibit 41: Analysis of erythropoietin biosimilar marketed products in Europe
Exhibit 42: PEST analysis: Erythropoietin drugs market in Europe 2016
Exhibit 43: Overview of erythropoietin drugs market in Americas (2016)
Exhibit 44: Erythropoietin drugs market in Americas 2016-2021 ($ billions)
Exhibit 45: Erythropoietin drugs market in US 2016-2021 ($ billions)
Exhibit 46: Erythropoietin drugs market in US: Opportunity analysis
Exhibit 47: PEST analysis: Erythropoietin drugs market in US
Exhibit 48: Overview of erythropoietin drugs market in APAC (2016)
Exhibit 49: Erythropoietin drugs market in APAC 2016-2021 ($ billions)
Exhibit 50: Market share of erythropoietin drugs in APAC
Exhibit 51: Erythropoietin drugs market in China 2016-2021 ($ millions)
Exhibit 52: China erythropoietin drugs market: Opportunity analysis
Exhibit 53: PEST analysis: Erythropoietin drugs market in China
Exhibit 54: Erythropoietin drugs market in Japan 2016-2021 ($ millions)
Exhibit 55: Erythropoietin drugs market in Japan 2016: Opportunity analysis
Exhibit 56: PEST analysis: Erythropoietin drugs market in Japan 2016
Exhibit 57: Impact of drivers and challenges in global erythropoietin drugs market
Exhibit 58: Patent analysis of biologicals in the US
Exhibit 59: Patent analysis of biologicals in Europe
Exhibit 60: Impact of drivers
Exhibit 61: Key reasons why physicians are reluctant to prescribe biosimilar drugs
Exhibit 62: Approval process of biologicals versus biosimilars via Public Health Service Act (PHSA) in US
Exhibit 63: Impact of drivers and challenges
Exhibit 64: Impact of trends in global erythropoietin drugs market
Exhibit 65: Few biosimilars currently under pipeline
Exhibit 66: Competitive structure analysis of global erythropoietin drugs market 2016
Exhibit 67: Geographical presence of key vendors
Exhibit 68: Competitive scenario: Global erythropoietin drugs market vendors 2016-2021
Exhibit 69: F. Hoffmann La-Roche: Key highlights
Exhibit 70: F. Hoffmann La-Roche: Strength assessment
Exhibit 71: F. Hoffmann La-Roche: Strategy assessment
Exhibit 72: F. Hoffmann La-Roche: Opportunity assessment
Exhibit 73: Amgen: Key highlights
Exhibit 74: Amgen: Strength assessment
Exhibit 75: Amgen: Strategy assessment
Exhibit 76: Amgen: Opportunity assessment
Exhibit 77: Johnson & Johnson: Profile
Exhibit 78: Johnson & Johnson: Strength assessment
Exhibit 79: Johnson & Johnson: Strategy assessment
Exhibit 80: Johnson & Johnson: Opportunity assessment
Exhibit 81: Kyowa Hakko Kirin: Highlights
Exhibit 82: Kyowa Hakko Kirin: Strength assessment
Exhibit 83: Kyowa Hakko Kirin: Strategy assessment
Exhibit 84: Kyowa Hakko Kirin: Opportunity assessment
【レポート販売概要】
■ タイトル：エリスロポエチン（EPO）薬の世界市場2017-2021■ 英文：Global Erythropoietin Drugs Market 2017-2021
■ 発行日：2017年3月7日
■ 調査会社：Technavio
■ 商品コード：IRTNTR12169
■ 調査対象地域：グローバル
- 世界の半導体市場2015-2020The Global Semiconductor Market 2015- 2020 is GMR Data’s latest Tech sector report. This report forecasts revenues for key services across key geographies. The global semiconductor market is forecast, by GMR Data, to reach $332bn across 2015, representing a 3.4% growth in comparison to $316bn in 2014. GMR Data forecasts that the market will grow at a 5-yr CAGR of 2.9% over 2015 to 2020, with the m …
- カジノゲーム装置の世界市場2017-2021：カジノテーブル、スロットマシーン、ゲームチップ、ビデオポーカー機械About Casino Gaming Equipment The global casino gaming equipment market is expected to grow at a CAGR of 15.25% during the forecast period. The easing of government regulations related to casino markets is one of the major factors contributing to the growing demand for casino gaming equipment. Many countries, such as Japan, are aiming at legalizing casino gaming because of the growing popularity o …
- 蛋白質成分の世界市場：動物性蛋白質（牛乳、乳清、ゼラチン、カゼイン、卵）、植物性蛋白質（野菜、大豆、小麦、エンドウ）The latest report from business intelligence provider visiongain offers comprehensive analysis of the global protein ingredients market. Visiongain assesses that this market will generate revenues of $27.70bn in 2015. Now: “Protein: a trending functional food ingredient in Europe”. This is an example of the business critical headline that you need to know about - and more importantly, you need to …
- 世界の防錆剤市場動向（2014-2018）TechNavio's analysts forecast the Global Corrosion Inhibitors market to grow at a CAGR of 4.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand for corrosion inhibitors from developing economies. The Global Corrosion Inhibitors market has also been witnessing the increase in market share of key players through mergers and acquisit …
- 拡張現実の世界市場2017-202：モバイルデバイス、スマートグラス、HMD（ヘッドマウントディスプレイ）About Augmented RealityAR technology is used to blend digital content into the physical world. Computer-generated images of an individual's surroundings along with relevant information are displayed in a user’s field of vision. The technology enhances user experience through mobiles apps developed specifically for using AR. The concept of AR has existed for several decades, although it has just ga …
- インテリジェントネットワークの世界市場：用途別（情報認識、トラフィック予測・分類、リソース管理・ネットワークの採択、パフォーマンス予測・コンフィギュレーションの外挿）、エンドユーザー別、サイズ別、地域別予測Global Intelligent Network Market to reach USD 10 billion by 2025. Global Intelligent Network Market valued approximately USD 1.16 billion in 2016 is anticipated to grow with a healthy growth rate of more than 27% over the forecast period 2017-2025. information cognition is expected to have a larger market share during the forecast period, as there is an increasing need for information cognition f …
- 受動光ネットワーク（PON）の世界市場分析：構造別（GPON、EPON、WDM-PON）、構成要素別（OLT、ONT）、用途別（FTTx、モバイルバックホール）、地域別（北アメリカ、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）、セグメント予測2014-2025The global Passive Optical Network (PON) market is expected to reach USD 43.43 billion by 2025, according to a new report conducted by Grand View Research, Inc. Passive optical network equipment offers higher efficiency with better bandwidth and utilizes larger variable length packets. The telecom operators in the industry are transitioning their switches from fiber to the business to the fiber to …
- 抗菌医療用テキスタイルの世界市場分析：仕上げ剤別（第四級アンモニウム、トリクロサン、金属塩）、用途別（埋め込み用、埋め込み不可、ヘルスケア･衛生用品）、セグメント予測The global antimicrobial medical textiles market is expected to reach USD 799.7 million by 2024, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases, an upsurge in the nosocomial infections worldwide, and growing awareness towards better healthcare practices are projected to fuel the demand for the product over the forecast period. Application of polymeric …
- Epidermolysis Bullosa：グローバル臨床試験レビューH2, 2013Epidermolysis Bullosa Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H2, 2013" provides data on the Epidermolysis Bullosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Epidermolysis Bullosa. It includes an overview of the trial numbers and the …
- 位置情報分析のグローバル市場動向(2014 – 2019)The location analytics market analysis consists of various types of software, services, applications, deployment types, organization size, verticals, and regions. The overall market size is found by adding up the market size of each solution and services such as consulting services and system integration services. In location analytics, each solution and service is playing an important role in the …
- 好中球減少症治療薬の世界市場About Neutropenia Treatment Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible t …
- 世界の画像診断サービス市場：処置別（MRI、超音波、X線、CT、核イメージング（SPECT、PET）、マンモグラフィ）、用途別（OB / Gyn、整形外科、腫瘍学、血管、神経学）、エンドユーザー別（病院、イメージングセンター）The diagnostic imaging services market is projected to grow at a CAGR of 5.1% during the forecast period. The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1% from 2019 to 2024. The major factors driving the growth of this market include the rapidly growing geriatric population and the subsequent increase in the pr …
- タイル接着剤および石材接着剤の世界市場予測（～2021年）The global market size for tile adhesives & stone adhesives is estimated to reach USD 4.10 Billion by 2021 and is projected to register a CAGR of 9.4% during the forecast period. The market is driven by rise in infrastructure spending by Asia-Pacific countries, increase in awareness about the benefits of tile adhesives, rise in ceramic tile demand, and increasing urbanization. Repairs & renovation …
- Retinal Vein Occlusion：グローバル臨床試験レビューH1, 2013Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013" provides data on the Retinal Vein Occlusion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinal Vein Occlusion. It includes an overview of the trial numbers and …
- フード及び飲料分野プラスチックのグローバル市場動向2011-2016（Food & Beverage Plastics – A Global Market Watch, 2011 – 2016）Global Market Watch: Global Food and Beverages Plastics is expected to reach US$71.5 billion by 2016, primarily supported by the end-user ? Fruit and Vegetables, Dairy, Bakery and Bottles/Containers. Globally, Fruit and Vegetables and Bottles/Containers together account for approximately 40% of the market are expected to support the Food and Beverages plastics industry going forward. Geographical …
